Porcine cytomegalovirus/porcine roseolovirus (PCMV/PRV): A threat for xenotransplantation?

Xenotransplantation. 2022 Sep;29(5):e12775. doi: 10.1111/xen.12775. Epub 2022 Sep 8.

Abstract

The potential for a donor-derived transmission of porcine cytomegalovirus/porcine roseolovirus (PCMV/PRV) to the recipient has been recognized since pigs were considered candidate donors for xenotransplantation. This review gives a short description of the viral properties and summarizes the current evidence of the effects of PCMV/PRV transmission in preclinical xenotransplantation. Despite evidence that PCMV/PRV does not infect human and non-human primate cells, activation in the transplanted organ and detrimental systemic complications have been described. As PCMV/PRV is a herpesvirus able to establish latency, the importance of adequate screening of donor pigs is emphasized, as no efficient treatment is available. Furthermore, easy and successful ways of elimination of PCMV/PRV from pig herds are indicated.

Keywords: PCR methods; Western blot analysis; herpes viruses; porcine cytomegalovirus; porcine roseolovirus; xenotransplantation.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytomegalovirus / physiology
  • Cytomegalovirus Infections* / veterinary
  • Humans
  • Primates
  • Roseolovirus*
  • Swine
  • Tissue Donors
  • Transplantation, Heterologous